John Fedele

John J. Fedele

Baker & McKenzie LLP


John Fedele is a member of Baker McKenzie's antitrust practice and is located in its Washington, DC office. While he has a broad range of antitrust experience, he most frequently represents clients before the Antitrust Division of the US Department of Justice (DOJ) and the Federal Trade Commission (FTC) in investigations of proposed mergers and acquisitions, and routinely analyzes and manages filing obligations under the Hart-Scott-Rodino (HSR) Act and foreign competition regimes.

Practice Focus

Mr. Fedele focuses his practice on a wide range of antitrust matters. In addition to representing clients in investigations of mergers and acquisitions before the FTC and DOJ, Mr. Fedele provides antitrust counsel to companies on a variety of commercial activity including distribution agreements, joint venture arrangements, and supply agreements, as well as works with companies to evaluate their antitrust compliance programs. His representations span a broad range of industries including, among others, finance, healthcare, medical devices, waste, energy, and chemicals.

Representative Legal Matters

  • Advised the Safran Group on the international and U.S. competition and regulatory aspects of its sale of Morpho Detection, a leading explosive and chemical detection company, to Smiths Detection, a division of Smiths Group. The transaction received significant scrutiny from the Antitrust Division and was a finalist for the Global Competition Review’s 2018 Merger Control Matter of the Year (Americas).
  • Advised CLARCOR Inc., a major manufacturer of filtration products, on the U.S. antitrust aspects of its USD 4.3 billion sale to Parker Hannifin Corporation.
  • Advised Fresenius Medical Care AG & Co. KgaA, one of the largest suppliers of outpatient dialysis services in the United States, in the Federal Trade Commission's investigation of its acquisition of Liberty Dialysis Holdings, Inc. The transaction was valued at approximately USD2.1 billion and involved over 100 distinct geographic markets.
  • Advised Gardner Denver, Inc., a worldwide compressor manufacturer, in its USD3.9 billion sale to Kohlberg, Kravis Roberts & Co. L.P. (KKR), a global investment firm.
  • Advised One Equity Partners on its acquisition of Sonneborn, Inc., one of the world's largest dedicated suppliers of white oils, petrolatums, waxes and other hydrocarbon specialty products, including the coordination of premerger notifications in multiple jurisdictions.
  • Advised Prestige Brands Holdings, Inc. on its acquisition of seventeen brands from GlaxoSmithKline, including the coordination of premerger notifications in multiple jurisdictions.
  • Advised Stericycle, Inc., the largest supplier of medical waste collection and treatment services, in the Antitrust Division's investigations of its acquisitions of its largest domestic competitors, Healthcare Waste Solutions and Medserve, Inc.
  • Advised Labinal, Inc., a company of the Safran Group, on its acquisition of Harvard Custom Manufacturing, Inc., a manufacturer of electrical wiring systems for commercial and military aerospace applications, and performed all merger-control analyses.

Professional Honors

  • “Competition – Future Leader,” Who’s Who Legal 2018

Professional Associations and Memberships

  • American Bar Association, Antitrust  Section - Joint Conduct Committee Vice-Chair
  • American Health Lawyer’s Association - Member


  • U.S. District Court, District of Columbia~United States (2010)
  • U.S. District Court, Central District of California~United States (2008)
  • U.S. Court of Appeals, Ninth Circuit~United States (2007)
  • District of Columbia~United States (2007)
  • U.S. District Court, Southern District of New York~United States (2004)
  • New York~United States (2004)


  • New York University School of Law (J.D., cum laude) (2003)
  • Harvard University (B.A., magna cum laude) (2000)


  • English
  • Spanish


  • Co-author, "United States: President Biden issues Executive Order to promote Vigorous Antitrust Enforcement in Key Markets," Baker McKenzie InsightPlus, 12 July 2021

  • Co-author, "Think Again—Allocating Antitrust Risk in a Climate of Protracted Investigations," CPI Antitrust Chronicle, May 2016

  • Author, International Activities chapter of the Corporate Legal Compliance Handbook, Wolters Kluwer, 2016

  • Author, "The Doctrine of ‘Unfairness’ and Its Affect on Global Competition Policy," Concurrences, 2013

  • Author, "The Rise of Challenges to Non-Reportable Transactions in the U.S. and Abroad," Global Competition Review, August/September 2011

  • Author, U.S. chapter of the Global Merger Control Manual, 9th Edition, Cameron May, 2011